| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
1 From the Departments of Pathology and 2 Mathematics, Statistics, and Computer Science, University of Illinois at Chicago, Chicago, Illinois; and the 3 Department of Ophthalmology, Hadassah University Hospital, Jerusalem, Israel.
PURPOSE. Aggressive melanoma cells may express endothelial markers that can be used to calculate microvascular density (MVD). High MVD has been associated with adverse outcome in uveal melanoma. If tumor cells label with endothelial cell markers, then MVD may not accurately reflect a tumor’s vascularity. This study was designed to study the influence of melanoma cell labeling by endothelial cell markers on MVD.
METHODS. Tissue sections of 200 ciliary body or choroidal melanomas were stained with CD34 alone, and the MVD was calculated by counting discrete foci of CD34 labeling in hot spots, as described previously. From adjacent sections double labeled by fluorescent immunohistochemical stains for S100 protein and CD34, tumor cells labeling with both markers were identified. The relationship between marker coexpression and MVD was tested. Tissue sections were also double labeled for Melan-A and CD34.
RESULTS. MVD was found to be associated with death from metastatic melanoma as reported previously. However, colocalization of both Melan-A and S100 protein with CD34 was demonstrated. The labeling of tumor cells by CD34 was associated with an elevated calculation of MVD (P < 0.0001) but not with cell type, mitotic figures, tumor-infiltrating lymphocytes, or PAS-positive patterns.
CONCLUSIONS. CD34 may label uveal melanoma cells and may contribute to computation of MVD. Although MVD is prognostically significant in uveal melanoma, this feature is not an exclusive measure of tumor vascularity.
This article has been cited by other articles:
|
|
 |
|
  R. Folberg, L. Leach, K. Valyi-Nagy, A. Y. Lin, M. A. Apushkin, Z. Ai, V. Barak, D. Majumdar, J. Pe'er, and A. J. Maniotis Modeling the Behavior of Uveal Melanoma in the Liver Invest. Ophthalmol. Vis. Sci., July 1, 2007; 48(7): 2967 - 2974. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Folberg, Z. Arbieva, J. Moses, A. Hayee, T. Sandal, S. Kadkol, A. Y. Lin, K. Valyi-Nagy, S. Setty, L. Leach, et al. Tumor Cell Plasticity in Uveal Melanoma: Microenvironment Directed Dampening of the Invasive and Metastatic Genotype and Phenotype Accompanies the Generation of Vasculogenic Mimicry Patterns Am. J. Pathol., October 1, 2006; 169(4): 1376 - 1389. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W.-Y. Yue and Z.-P. Chen Does Vasculogenic Mimicry Exist in Astrocytoma? J. Histochem. Cytochem., August 1, 2005; 53(8): 997 - 1002. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. S. Stein Mechanogenomic Control of DNA Exposure and Sequestration Am. J. Pathol., April 1, 2005; 166(4): 959 - 962. [Full Text] [PDF]
|
|
|
|
|
|
P. Toivonen, T. Makitie, E. Kujala, and T. Kivela Microcirculation and Tumor-Infiltrating Macrophages in Choroidal and Ciliary Body Melanoma and Corresponding Metastases Invest. Ophthalmol. Vis. Sci., January 1, 2004; 45(1): 1 - 6. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Kivela and P. M. Grambsch Evaluation of Sampling Strategies for Modeling Survival of Uveal Malignant Melanoma Invest. Ophthalmol. Vis. Sci., August 1, 2003; 44(8): 3288 - 3293. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R.'a T. Al-Jamal, T. Makitie, and T. Kivela Nucleolar Diameter and Microvascular Factors as Independent Predictors of Mortality from Malignant Melanoma of the Choroid and Ciliary Body Invest. Ophthalmol. Vis. Sci., June 1, 2003; 44(6): 2381 - 2389. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
